AbstractAdaptation of antibody neutralization-resistant human immunodeficiency virus type I (HIV-1) to growth in vitro generally results in the acquisition of a neutralization-sensitive phenotype, an alteration of viral growth kinetics, and an array of amino acid substitutions associated with these changes. Here we examine a panel of Env chimeras and mutants derived from these neutralization-resistant and -sensitive parental Envs. A range of neutralization and infectivity phenotypes was observed. These included a modulation of the CD4 binding site (CD4bs) towards recognition by neutralizing and non-neutralizing CD4bs-directed antibodies, resulting in a globally neutralization-sensitive Env; alterations which affected Env complex stability; ...
AbstractPrimary strains of human immunodeficiency virus type 1 (HIV-1) are known to adapt to replica...
HIV-1 affects over 34 million people worldwide. Although there is no vaccine, some patients develop ...
AbstractLittle is known about the neutralization properties of HIV-1 in India to optimally design an...
Background: The rapid and continual viral escape from neutralizing antibodies is well documented in ...
AbstractIn this study, progeny viruses of four HIV-1 molecular clones were tested for sensitivity to...
Background: The rapid and continual viral escape from neutralizing antibodies is well documented in ...
AbstractThe target for neutralizing antibodies against human immunodeficiency virus (HIV) is the tri...
The relative resistance of human immunodeficiency virus type 1 (HIV-1) primary isolates (PIs) to neu...
BACKGROUND: The rapid and continual viral escape from neutralizing antibodies is well documented in ...
AbstractIdentification of vulnerability in the HIV-1 envelope (Env) will aid in Env-based vaccine de...
AbstractThe detailed interactions between antibodies and the HIV-1 envelope protein that lead to neu...
AbstractIn the present study by examining pseudoviruses expressing patient chimeric envelopes (Envs)...
AbstractNeutralizing antibodies (Nabs) are thought to play an important role in prevention and contr...
Human Immunodeficiency Virus (HIV-1) is an epidemic that affects over 34 million people worldwide. A...
AbstractEndoproteolytic processing of the human immunodeficiency virus type 1 (HIV-1) envelope (Env)...
AbstractPrimary strains of human immunodeficiency virus type 1 (HIV-1) are known to adapt to replica...
HIV-1 affects over 34 million people worldwide. Although there is no vaccine, some patients develop ...
AbstractLittle is known about the neutralization properties of HIV-1 in India to optimally design an...
Background: The rapid and continual viral escape from neutralizing antibodies is well documented in ...
AbstractIn this study, progeny viruses of four HIV-1 molecular clones were tested for sensitivity to...
Background: The rapid and continual viral escape from neutralizing antibodies is well documented in ...
AbstractThe target for neutralizing antibodies against human immunodeficiency virus (HIV) is the tri...
The relative resistance of human immunodeficiency virus type 1 (HIV-1) primary isolates (PIs) to neu...
BACKGROUND: The rapid and continual viral escape from neutralizing antibodies is well documented in ...
AbstractIdentification of vulnerability in the HIV-1 envelope (Env) will aid in Env-based vaccine de...
AbstractThe detailed interactions between antibodies and the HIV-1 envelope protein that lead to neu...
AbstractIn the present study by examining pseudoviruses expressing patient chimeric envelopes (Envs)...
AbstractNeutralizing antibodies (Nabs) are thought to play an important role in prevention and contr...
Human Immunodeficiency Virus (HIV-1) is an epidemic that affects over 34 million people worldwide. A...
AbstractEndoproteolytic processing of the human immunodeficiency virus type 1 (HIV-1) envelope (Env)...
AbstractPrimary strains of human immunodeficiency virus type 1 (HIV-1) are known to adapt to replica...
HIV-1 affects over 34 million people worldwide. Although there is no vaccine, some patients develop ...
AbstractLittle is known about the neutralization properties of HIV-1 in India to optimally design an...